Skip to main content
OpenTrials

Clinical trial condition

Nephritis

Explore clinical trials studying Nephritis. Study availability and eligibility vary by location and protocol.

616 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Nephritis trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis

NCT04221477

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of Alabama at Birmingham Medical Center Birmingham, Alabama, United States
  • Wallace Rheumatic Study Center Beverly Hills, California, United States
  • Kaiser Permanente - Fontana Fontana, California, United States
  • Kaiser Permanente - San Francisco Medical Center San Francisco, California, United States
View all 74 locations
View Trial Details
Active, Not Recruiting

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

NCT05248646

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham - Site #336 Birmingham, Alabama, United States
  • Mayo Clinic Arizona - Site #363 Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences - Site #353 Little Rock, Arkansas, United States
  • Amicis Research Center - Site #341 Granada Hills, California, United States
View all 308 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

NCT06544330

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Feinstein Institutes for Medical Research Manhasset, New York, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

NCT07219121

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cornell Medical Center New York, United States
  • University of North Carolina Chapel Hill Morrisville, North Carolina, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +20 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 246 locations
View Trial Details
Active, Not Recruiting

Atrasentan in Patients With IgA Nephropathy

NCT04573478

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Research Institute Alhambra, California, United States
  • Kidney Disease Medical Group Glendale, California, United States
  • Stanford University Stanford, California, United States
View all 135 locations
View Trial Details

Related conditions